AFP (Alpha Feto Protein)
Report Delivery Time: Same Day
Recommended Gender: Both
Sample Type: Blood
The Alpha-Fetoprotein (AFP) test measures AFP levels in the blood and is primarily used for screening liver cancer (hepatocellular carcinoma), germ cell tumors, and monitoring fetal development during pregnancy.
₹700.00
+919354028488
Email Address
info@hprimelabs.com
Email Address
customercare@hprimelabs.com
Related Packages
Advanced Full Body Checkup for Females
Report Delivery: 12 hours
Parameters: 14
Gender: Both
Sample: Blood, Urine
Immunity Health Checkup
Report Delivery: 12 hours
Parameters: 16
Gender: Both
Sample: Blood
Related Tets
Activated Partial Thromboplastin Time (APTT / PTTK)
Report Delivery: Same Day
Parameters: 1
Gender: Both
Sample: Blood
The Activated Partial Thromboplastin Time (APTT / PTTK) test measures how long it takes for blood to clot, helping assess bleeding disorders, clotting factor deficiencies, and the effectiveness of anticoagulant therapy.
ACTH (Adreno Cortico Tropic Hormone)
Report Delivery: Next Day
Parameters: 1
Gender: Both
Sample: Blood
The Adrenocorticotropic Hormone (ACTH) test measures the level of ACTH in the blood, which helps evaluate adrenal gland function, diagnose hormonal imbalances, and assess conditions like Cushing’s syndrome and Addison’s disease.
The Alpha-Fetoprotein (AFP) test is a blood test that measures the amount of AFP, a protein normally produced by the fetal liver and yolk sac. In adults, elevated AFP levels may indicate liver diseases (such as cirrhosis or hepatitis), liver cancer, or germ cell tumors (testicular or ovarian cancer). In pregnant women, this test is used as part of prenatal screening to assess fetal health and detect potential birth defects such as neural tube defects (spina bifida) and chromosomal abnormalities.
What’s Included in This Test?
- Measurement of AFP levels in blood
- Screening for liver cancer (Hepatocellular carcinoma – HCC)
- Detection of germ cell tumors (testicular & ovarian cancer)
- Prenatal screening for fetal abnormalities
- Monitoring liver disease and cancer treatment response
Recommended Gender:
Suitable for both men and women Used in pregnancy screening for fetal health assessment
Test Details:
- Sample Type: Serum (1mL)
- Method: CLIA (Chemiluminescent Immunoassay)
This test is essential for cancer detection, liver disease monitoring, and prenatal screening, helping in early diagnosis and effective treatment planning.
Scan This QR Code